VPS13A Activators are a collection of chemical compounds that directly or indirectly facilitate the enhancement of VPS13A's functional activity, most notably its role in lipid transport between cellular membranes. Phosphatidylserine, a signaling lipid, has a pivotal role in cellular signaling related to membrane dynamics, and its increased presence on the outer membrane leaflet is a direct activator of VPS13A's lipid transfer function. Similarly, the lipid derivatives such as arachidonic acid, sphingosine, lysophosphatidic acid, ceramide, and diacylglycerol, through their respective signaling pathways, bolster the activity of VPS13A, emphasizing the protein's intricate involvement in cellular lipid regulation. Additionally, compounds like forskolin and the calcium ionophore A23187 indirectly activate VPS13A by elevating intracellular levels of cAMP and calcium, respectively, which cascade into events that promote VPS13A's lipid shuttling activity.
On the other hand, small molecules such as U18666A and the lipid component SM-102 engage with VPS13A activity by perturbing the homeostasis of lipid compartments or integrating into lipid nanocomplexes, leading to the activation of VPS13A as a response to maintain cellular lipid equilibrium. The presence of PIP2 enhances VPS13A's activity due to its integral role in membrane signaling and as a precursor for various lipid messengers. Nicotinic acid, known for its effects on lipid metabolism, may also lead to an upsurge in VPS13A activity, highlighting the protein's significant role in managing the complex lipid environment within the cell. Collectively, these chemical activators underscore the critical function of VPS13A in lipid transport and cellular homeostasis, acting through a myriad of signaling pathways and molecular interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $78.00 | ||
Phosphatidylserine on the outer leaflet of membranes can serve as a specific signal for the activation of VPS13A, which is implicated in the translocation of lipids between membranes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
The calcium ionophore A23187 elevates intracellular calcium levels, which may enhance VPS13A activation due to its potential role in calcium-mediated signaling pathways. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $90.00 $235.00 $4243.00 | 9 | |
Arachidonic acid can be metabolized into eicosanoids, which modulate various signaling pathways, potentially enhancing the VPS13A activation as it is involved in lipid transport and may be regulated by lipid signaling. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $88.00 $190.00 $500.00 $2400.00 $9200.00 $15000.00 | 2 | |
As a bioactive lipid, sphingosine may influence lipid signaling pathways and thereby enhance the activation of VPS13A, which has a role in lipid transfer. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
Lysophosphatidic acid acts on its receptors to activate downstream signaling pathways that can enhance the functional activity of VPS13A in lipid transport. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises intracellular cAMP levels, which may activate PKA and other cAMP-dependent pathways, leading to the enhancement of VPS13A's function in lipid transfer. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $77.00 $316.00 | 12 | |
Ceramide participates in the regulation of signaling pathways, which may enhance the activity of VPS13A in the maintenance of cellular lipid composition. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $140.00 $500.00 | 2 | |
U18666A disrupts cholesterol trafficking and may lead to the activation of VPS13A as it compensates for perturbations in lipid homeostasis. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $46.00 $249.00 | 2 | |
DAG is a second messenger that may enhance the activity of VPS13A through protein kinases C (PKC) signaling pathways. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Nicotinic acid has been shown to influence lipid metabolism, which could lead to an enhancement of VPS13A activity due to its involvement in lipid transport. | ||||||